Generic drug entry prior to patent expiration an FTC study - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Generic drug entry prior to patent expiration an FTC study write by . This book was released on 2002. Generic drug entry prior to patent expiration an FTC study available in PDF, EPUB and Kindle.
Generic Drug Entry Prior to Patent Expiration
Generic Drug Entry Prior to Patent Expiration - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Generic Drug Entry Prior to Patent Expiration write by United States. Federal Trade Commission. This book was released on 2002-01-01. Generic Drug Entry Prior to Patent Expiration available in PDF, EPUB and Kindle. "In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendments provide certain methods by which generic drug manufacturers can obtain approval to market a generic version of a brand-name product. The study's purpose was to provide a more complete picture of how generic drug competition has developed under one method the Amendments established: generic entry prior to expiration of the brand-name company's patents on the relevant drug product. This report sets forth the results of the study. The study was prompted, in part, by the Commission's enforcement actions against alleged anticompetitive agreements that relied on certain Hatch-Waxman provisions. The study was designed to determine whether such agreements are isolated instances or more typical, and whether particular provisions of the Hatch-Waxman Amendments are susceptible to strategies to delay or deter consumer access to low-cost generic alternatives to brand-name drug products." -- from the Introduction, p. 1.
Generic Drug Entry Prior to Patent Expiration
Generic Drug Entry Prior to Patent Expiration - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Generic Drug Entry Prior to Patent Expiration write by United States. Federal Trade Commission. This book was released on 2002. Generic Drug Entry Prior to Patent Expiration available in PDF, EPUB and Kindle. In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendments provide certain methods by which generic drug manufacturers can obtain approval to market a generic version of a brand-name product. The study's purpose was to provide a more complete picture of how generic drug competition has developed under one method the Amendments established: generic entry prior to expiration of the brand-name company's patents on the relevant drug product.
Making Medicines Affordable
Making Medicines Affordable - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Making Medicines Affordable write by National Academies of Sciences, Engineering, and Medicine. This book was released on 2018-03-01. Making Medicines Affordable available in PDF, EPUB and Kindle. Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Drug Wars
Drug Wars - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Drug Wars write by Robin Feldman. This book was released on 2017-06-09. Drug Wars available in PDF, EPUB and Kindle. While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
